Finance

Lists
GLSI:NASDAQ
Greenwich Lifesciences Inc
$15.14
+0.77%
(+0.12) 1D
Sep 10, 12:05:03 PM GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for GLSI...
Open
$14.54
High
$15.34
Low
$14.46
Mkt. cap
222.30M
Avg. vol.
120.74K
Volume
17.72K
52-wk high
$34.10
52-wk low
$7.78
EPS
-$1.53
Beta
1.47
Shares outstanding
14.68M
No. of employees
4
Open
$14.54
High
$15.34
Low
$14.46
Mkt. cap
222.30M
Avg. vol.
120.74K
Volume
17.72K
52-wk high
$34.10
52-wk low
$7.78
EPS
-$1.53
Beta
1.47
Shares outstanding
14.68M
No. of employees
4
About Greenwich Lifesciences Inc
CEO-
Employees4
Founded2006
HeadquartersStafford, Texas, United States
SectorBiotechnology
Analyst ratings
Based on 1 analyst giving stock ratings to GLSI in the past 3 months
Buy
Buy
1
Hold
0
Sell
0
12-month forecast
Based on 1 Wall Street analyst offering 12-month price targets for GLSI in the last 3 months
Highest
Current $15.14
$69.00 (+355.60%)
Average
$69.00 (+355.60%)
Lowest
$69.00 (+355.60%)
Analyst
Recommendation
Action
Price target
Projected
Date
Yi Chen
H.C. Wainwright
Buy
Reiterated
$69.00
+355.6%
07/21/2026
Robert LeBoyer
Noble Financial
Buy
Reiterated
$45.00
+197.1%
06/02/2026
Previous reportsAll values in USD
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in USD
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Revenue
-
-
-
-
Cost of goods sold
-
-
-
-
Cost of revenue
-
-
-
-
Research and development expenses
3.52M
7.59M
5.21M
3.56M
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
653.07K
355.19K
518.19K
462.93K
Operating expense
4.17M
7.94M
5.73M
4.02M
Total operating expenses
4.17M
7.94M
5.73M
4.02M
Operating income
-4.17M
-7.94M
-5.73M
-4.02M
Other non operating income
-
-
-
-
EBT including unusual items
-4.15M
-7.92M
-5.66M
-3.95M
EBT excluding unusual items
-4.15M
-7.92M
-5.66M
-3.95M
Income tax expense
-
-
-
-
Effective tax rate
-
-
-
-
Other operating expenses
-
-
-
-
Net income
-4.15M
-7.92M
-5.66M
-3.95M
Net profit margin
-
-
-
-
Earnings per share
-
-
-
-
Interest and investment income
22.80K
22.26K
68.62K
72.97K
Interest expense
-
-
-
-
Net interest expenses
22.80K
22.26K
68.62K
72.97K
Depreciation and amortization charges
-
-
-
-
EBITDA
-4.17M
-7.94M
-5.73M
-4.02M
Gain or loss from assets sale
-
-
-
-
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
AI content may include mistakes. Learn more
Google apps